Biogenesis
PrivateLast Round
Seed
Mar 1, 2024
Total Funding Raised
$2.75M
Company Overview
Biogenesis is a healthcare technology company that provides an AI-powered platform designed to accelerate clinical trials by matching pharmaceutical organizations with suitable clinical research sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Workflow Automation, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biogenesis Comparables
Compare Biogenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inato | 79% | |
| Paradigm Health | 75% | |
| TriNetX | 74% | |
Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2024 | ||||
| Pre Seed | Oct 2, 2022 |
Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UC LAUNCH | Pre Seed |
| Alt Capital | Seed |
| Kleiner Perkins | Pre Seed |
| Nucleate | Pre Seed |
| Pareto Holdings | Pre Seed |
| Z Fellows | Pre Seed |
| Formic Ventures | Pre Seed |
Biogenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biogenesis's valuation, stock price, and market status.